文献速递老年精神儿童青少年精神

注意缺陷多动障碍与晚年认知损害相关

Attention-Deficit/Hyperactivity Disorder and Late-Life Cognitive Impairment.
PubMed 文献 · JAMA Psychiatry · 2026-10-07

基于美国All of Us研究项目187 341名50岁及以上参与者的队列研究显示,ADHD诊断与认知损害(MCI或痴呆)发病风险升高相关(HR 4.60,95%CI 3.99-5.29,P<.001),ADHD多基因风险评分亦与认知损害相关(最高vs最低五分位HR 1.35,95%CI 1.25-1.46,P<.001)。在已发生认知损害的参与者中,共病ADHD诊断与更差的心理健康、生活质量、社会满意度及更高的医疗利用相关。

要点

  • ADHD诊断与晚年认知损害风险升高相关,校正共病、教育程度和医疗利用后关联仍存在。
  • ADHD多基因风险评分最高五分位者认知损害风险高于最低五分位者(HR 1.35)。
  • 认知损害者中共病ADHD与更差心理健康、生活质量、社会满意度及更高医疗利用相关。

核心结论

  • 临床与遗传证据汇聚显示,ADHD与晚年认知损害风险显著升高相关。
  • 在发生认知损害的人群中,ADHD诊断与更差的健康结局和更高的医疗利用相关,提示需针对性监测与整合照护。

研究设计与样本

  • 队列研究,使用美国All of Us研究项目数据,入组时间2018年5月6日至2023年10月1日,电子健康记录数据至2023年10月1日,平均随访10.26(SD 6.75)年。
  • 共纳入187 341名50岁及以上、有电子健康记录和基因组数据的参与者,数据分析时间为2025年10月至2026年7月。

主要发现

  • 参与者平均年龄56.41(SD 7.88)岁,107 266人(57%)为女性,3026人(1.6%)有ADHD。
  • ADHD组203人(6.7%)发生认知损害,非ADHD组6259人(3.4%)发生认知损害。
  • 校正Cox模型中,ADHD与认知损害风险升高相关(HR 4.60,95%CI 3.99-5.29,P<.001),校正共病、教育程度和医疗利用后关联减弱但未消除。
  • ADHD多基因风险评分最高五分位与最低五分位相比,认知损害风险升高(HR 1.35,95%CI 1.25-1.46,P<.001)。
  • 在发生认知损害的参与者中,共病ADHD诊断与更差心理健康(OR 1.69,95%CI 1.18-2.39,P=.01)、生活质量(OR 1.66,95%CI 1.14-2.39,P=.02)、社会满意度(OR 2.39,95%CI 1.69-3.37,P<.001)及更高医疗利用(IRR 1.20,95%CI 1.09-1.34,P=.003)相关。

临床怎么用

  • 对ADHD成人患者应关注晚年认知功能变化,考虑针对性监测。
  • 对已发生认知损害的ADHD患者,需关注心理健康、生活质量和社会功能,并考虑整合照护以应对更高医疗利用。

局限性

  • 原文未报告具体局限性内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Attention-deficit/hyperactivity disorder (ADHD) affects tens to hundreds of millions of adults worldwide, and preliminary evidence suggests it may be associated with increased risk of mild cognitive impairment (MCI) and dementia. However, concerns regarding diagnostic ascertainment and residual confounding remain. OBJECTIVE: To investigate the association of ADHD with incident cognitive impairment, defined as MCI or dementia, using electronic health record (EHR) diagnoses and genetic liability measured using genome-wide ADHD polygenic risk score (ADHD PRS) in the same individuals. DESIGN, SETTING, AND PARTICIPANTS: This cohort study used data from the US All of Us Research Program (enrollment May 6, 2018, to October 1, 2023; EHR data from January 4, 1985, to October 1, 2023; mean [SD] follow-up 10.26 [6.75] years). A total of 187 341 participants aged 50 years and older with available EHR and genomic data were included. Data were analyzed from October 2025 to July 2026. EXPOSURES: ADHD diagnosis and ADHD PRS. MAIN OUTCOMES AND MEASURES: Incident MCI or dementia. RESULTS: Among 187 341 participants (mean [SD] age, 56.41 [7.88] years; 107 266 [57%] female), 3026 (1.6%) had ADHD. Among participants with ADHD, 203 (6.7%) developed cognitive impairment, compared with 6259 (3.4%) among those without ADHD. In adjusted Cox models, ADHD was associated with a more than 4-fold higher hazard of cognitive impairment (hazard ratio [HR], 4.60; 95% CI, 3.99-5.29; P < .001). Adjustments for comorbidities, educational attainment, and health care utilization attenuated but did not eliminate the association. Similarly, ADHD PRS was associated with incident cognitive impairment (highest vs lowest quintile: HR, 1.35; 95% CI, 1.25-1.46; P < .001). Among participants who developed cognitive impairment, comorbid ADHD diagnosis was associated with a nearly 2-fold higher odds of suboptimal mental health (odds ratio [OR], 1.69; 95% CI, 1.18-2.39; P = .01), quality of life (OR, 1.66; 95% CI, 1.14-2.39; P = .02), social satisfaction (OR, 2.39; 95% CI, 1.69-3.37; P < .001), and 20% higher health care utilization (incidence rate ratio, 1.20; 95% CI, 1.09-1.34; P = .003), suggesting greater care burden beyond the elevated incidence risk. CONCLUSIONS AND RELEVANCE: In this cohort study, convergent clinical and genetic evidence revealed ADHD was associated with a markedly increased risk of late-life cognitive impairment. Among those who develop cognitive impairment, an ADHD diagnosis was associated with worse health outcomes and greater health care utilization, supporting the need for targeted monitoring and integrated care in this population.

来源:JAMA Psychiatry,查看原文。版权归原作者所有。

引用

  1. Bauer-Negrini G, Leffa DT, Ferreira PCL, et al. Attention-Deficit/Hyperactivity Disorder and Late-Life Cognitive Impairment. JAMA Psychiatry. 2026. PMID: 42842281. doi:10.1001/jamapsychiatry.2026.3165

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。